Wednesday, November 05, 2008

NCCN Updates Guidelines for Colorectal Cancer

"NCCN announces new updates to the NCCN Guidelines for Colon and Rectal Cancers. The updates include recommendations to the pre-treatment work-up and use of anti-cancer agents in patients with metastatic colorectal cancer depending on the status of the tumor’s KRAS gene. The changes are based on recent studies demonstrating that the tumor KRAS gene status is highly predictive of outcome with certain therapies."

Labels: , , ,

0 Comments:

Post a Comment